Incannex Healthcare forms 50:50 JV with Mind Medicine Australia for psychedelic therapy clinic

Incannex Healthcare Inc.

JV creates 'Mind Medicine Australia Clinics' to operate a clinic in Melbourne.
JV aims to reduce treatment costs and more than triple patient capacity for PTSD and depression.
Patient intake expected to begin shortly in response to strong early demand.
MMA led 2023 regulatory rescheduling of psilocybin and MDMA for clinical use in Australia.
Incannex CEO cites alignment with long-term shareholder value and commercialization model.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.